Clinical Trial Update: Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating denosumab in addition to intense urate-lowering therapy for bone erosions in gout patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Gout | Phase 2 | Status: COMPLETED | Results posted: 2021-08-31